{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T23:45:16Z","timestamp":1792107916595,"version":"4.4.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s00467-026-07478-1","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T04:01:09Z","timestamp":1784606469000},"page":"4647-4655","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Acute kidney injury and urinary drug crystals in children treated with tosufloxacin: a multicenter retrospective study"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3733-6563","authenticated-orcid":false,"given":"Yuji","family":"Matsumoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Itano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuma","family":"Ando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomomi","family":"Kondoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soichiro","family":"Ishimaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetaka","family":"Nakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Hirai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Kisohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naonori","family":"Kumagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Ikezumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"key":"7478_CR1","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1128\/AAC.00048-13","volume":"57","author":"Y Kawai","year":"2013","unstructured":"Kawai Y, Miyashita N, Kubo M et al (2013) Therapeutic efficacy of macrolides, minocycline, and tosufloxacin against macrolide-resistant Mycoplasma pneumoniae pneumonia in pediatric patients. Antimicrob Agents Chemother 57:2252\u20132258. https:\/\/doi.org\/10.1128\/AAC.00048-13","journal-title":"Antimicrob Agents Chemother"},{"key":"7478_CR2","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.resinv.2025.04.009","volume":"63","author":"N Miyashita","year":"2025","unstructured":"Miyashita N, Ogata M, Fukuda N et al (2025) Macrolide-resistant Mycoplasma pneumoniae infection prevalence increases again in Osaka. Respir Investig 63:517\u2013520. https:\/\/doi.org\/10.1016\/j.resinv.2025.04.009","journal-title":"Respir Investig"},{"key":"7478_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.00693","volume":"7","author":"T Yamazaki","year":"2016","unstructured":"Yamazaki T, Kenri T (2016) Epidemiology of Mycoplasma pneumoniae infections in Japan and therapeutic strategies for macrolide-resistant M. pneumoniae. Front Microbiol 7:693. https:\/\/doi.org\/10.3389\/fmicb.2016.00693","journal-title":"Front Microbiol"},{"key":"7478_CR4","doi-asserted-by":"publisher","DOI":"10.1111\/ped.15368","volume":"64","author":"Y Atsumi","year":"2022","unstructured":"Atsumi Y, Yamanaka H, Shimozawa K et al (2022) Drug-induced crystalluria attributable to tosufloxacin in children. Pediatr Int 64:e15368. https:\/\/doi.org\/10.1111\/ped.15368","journal-title":"Pediatr Int"},{"key":"7478_CR5","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1111\/ped.13116","volume":"58","author":"R Matsubara","year":"2016","unstructured":"Matsubara R, Kibe T, Nomura T (2016) Crystalline nephropathy caused by tosufloxacin. Pediatr Int 58:1219\u20131221. https:\/\/doi.org\/10.1111\/ped.13116","journal-title":"Pediatr Int"},{"key":"7478_CR6","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3165\/jjpn.oa.2018.0128","volume":"31","author":"N Sugawara","year":"2018","unstructured":"Sugawara N, Yamamura S, Takahashi A et al (2018) Adverse renal effects and serum creatinine elevation associated with tosufloxacin. Nihon Shoni Jinzobyo Gakkai Zasshi 31:30\u201336. https:\/\/doi.org\/10.3165\/jjpn.oa.2018.0128","journal-title":"Nihon Shoni Jinzobyo Gakkai Zasshi"},{"key":"7478_CR7","doi-asserted-by":"publisher","first-page":"231","DOI":"10.4103\/0971-4065.200522","volume":"27","author":"R Goli","year":"2017","unstructured":"Goli R, Mukku KK, Raju SB, Uppin MS (2017) Acute ciprofloxacin-induced crystal nephropathy with granulomatous interstitial nephritis. Indian J Nephrol 27:231\u2013233. https:\/\/doi.org\/10.4103\/0971-4065.200522","journal-title":"Indian J Nephrol"},{"key":"7478_CR8","doi-asserted-by":"publisher","first-page":"424","DOI":"10.4103\/ijn.IJN_295_18","volume":"29","author":"FA Ansari","year":"2019","unstructured":"Ansari FA, Manuel S, Dwivedi R et al (2019) A rare case of acute kidney injury due to levofloxacin-induced crystal nephropathy. Indian J Nephrol 29:424\u2013426. https:\/\/doi.org\/10.4103\/ijn.IJN_295_18","journal-title":"Indian J Nephrol"},{"key":"7478_CR9","doi-asserted-by":"publisher","unstructured":"Nagata K, Tanaka Y, Matsumoto M, Hashimoto A (2019) Characteristics of tosufloxacin crystals and crystal casts observed in urine sediment of infants. Jpn J Med Technol 68:751\u2013757. https:\/\/doi.org\/10.14932\/jamt.18-99","DOI":"10.14932\/jamt.18-99"},{"key":"7478_CR10","doi-asserted-by":"publisher","first-page":"c179","DOI":"10.1159\/000339789","volume":"120","author":"A Khwaja","year":"2012","unstructured":"Khwaja A (2012) KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract 120:c179\u2013c184. https:\/\/doi.org\/10.1159\/000339789","journal-title":"Nephron Clin Pract"},{"key":"7478_CR11","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1007\/s10157-011-0452-y","volume":"15","author":"O Uemura","year":"2011","unstructured":"Uemura O, Honda M, Matsuyama T et al (2011) Age, gender, and body length effects on reference serum creatinine levels determined by an enzymatic method in Japanese children: a multicenter study. Clin Exp Nephrol 15:694\u2013699. https:\/\/doi.org\/10.1007\/s10157-011-0452-y","journal-title":"Clin Exp Nephrol"},{"key":"7478_CR12","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1007\/s10157-013-0856-y","volume":"18","author":"O Uemura","year":"2014","unstructured":"Uemura O, Nagai T, Ishikura K et al (2014) Creatinine-based equation to estimate the glomerular filtration rate in Japanese children and adolescents with chronic kidney disease. Clin Exp Nephrol 18:626\u2013633. https:\/\/doi.org\/10.1007\/s10157-013-0856-y","journal-title":"Clin Exp Nephrol"},{"key":"7478_CR13","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s10157-023-02392-4","volume":"28","author":"S Okamoto","year":"2024","unstructured":"Okamoto S, Matsuyama T, Hamada R et al (2024) Reference values for urinary protein, albumin, beta 2-microglobulin, and the alpha 1-microglobulin-to-creatinine ratio in Japanese children. Clin Exp Nephrol 28:50\u201357. https:\/\/doi.org\/10.1007\/s10157-023-02392-4","journal-title":"Clin Exp Nephrol"},{"key":"7478_CR14","doi-asserted-by":"publisher","first-page":"643","DOI":"10.11150\/kansenshogakuzasshi.93.643","volume":"93","author":"T Tajima","year":"2019","unstructured":"Tajima T, Miyashita H, Mieno K et al (2019) Acute kidney injury after administration of tosufloxacin tosilate in children with Mycoplasma pneumoniae pneumonia. Kansenshogaku Zasshi 93:643\u2013648. https:\/\/doi.org\/10.11150\/kansenshogakuzasshi.93.643","journal-title":"Kansenshogaku Zasshi"},{"key":"7478_CR15","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/s0272-6386(04)01089-3","volume":"44","author":"H Okada","year":"2004","unstructured":"Okada H, Watanabe Y, Kotaki S et al (2004) An unusual form of crystal-forming chronic interstitial nephritis following long-term exposure to tosufloxacin tosilate. Am J Kidney Dis 44:902\u2013907. https:\/\/doi.org\/10.1016\/s0272-6386(04)01089-3","journal-title":"Am J Kidney Dis"},{"key":"7478_CR16","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.2169\/internalmedicine.3082-23","volume":"63","author":"Y Ito","year":"2024","unstructured":"Ito Y, Mori N, Matsuo K et al (2024) Evidence of tosufloxacin deposition in the kidneys of a patient presenting with crystal nephropathy. Intern Med 63:2833\u20132837. https:\/\/doi.org\/10.2169\/internalmedicine.3082-23","journal-title":"Intern Med"},{"key":"7478_CR17","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s13730-025-01007-z","volume":"14","author":"S Sainokami","year":"2025","unstructured":"Sainokami S, Watanabe H, Kanda S et al (2025) Renal and gastrointestinal complications following tosufloxacin therapy for suspected mycoplasma infection in a 10-year-old child. CEN Case Rep 14:713\u2013718. https:\/\/doi.org\/10.1007\/s13730-025-01007-z","journal-title":"CEN Case Rep"},{"key":"7478_CR18","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.2215\/CJN.11290821","volume":"17","author":"MA Perazella","year":"2022","unstructured":"Perazella MA, Rosner MH (2022) Drug-induced acute kidney injury. Clin J Am Soc Nephrol 17:1220\u20131233. https:\/\/doi.org\/10.2215\/CJN.11290821","journal-title":"Clin J Am Soc Nephrol"},{"key":"7478_CR19","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1053\/ajkd.1998.v31.pm9531191","volume":"31","author":"VR Dharnidharka","year":"1998","unstructured":"Dharnidharka VR, Nadeau K, Cannon CL et al (1998) Ciprofloxacin overdose: acute renal failure with prominent apoptotic changes. Am J Kidney Dis 31:710\u2013712. https:\/\/doi.org\/10.1053\/ajkd.1998.v31.pm9531191","journal-title":"Am J Kidney Dis"},{"key":"7478_CR20","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1159\/000168458","volume":"12","author":"JR Bailey","year":"1992","unstructured":"Bailey JR, Trott SA, Philbrick JT (1992) Ciprofloxacin-induced acute interstitial nephritis. Am J Nephrol 12:271\u2013273. https:\/\/doi.org\/10.1159\/000168458","journal-title":"Am J Nephrol"},{"key":"7478_CR21","doi-asserted-by":"publisher","first-page":"E475","DOI":"10.1503\/cmaj.121730","volume":"185","author":"ST Bird","year":"2013","unstructured":"Bird ST, Etminan M, Brophy JM et al (2013) Risk of acute kidney injury associated with the use of fluoroquinolones. CMAJ 185:E475\u2013E482. https:\/\/doi.org\/10.1503\/cmaj.121730","journal-title":"CMAJ"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-026-07478-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-026-07478-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-026-07478-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:54:24Z","timestamp":1792104864000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-026-07478-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":21,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["7478"],"URL":"https:\/\/doi.org\/10.1007\/s00467-026-07478-1","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,21]]},"assertion":[{"value":"3 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This multicenter retrospective study was approved by the Institutional Review Board of Fujita Health University (approval number: HM25-218). Participating institutions provided anonymized data under the approval of the lead institution. The study was conducted in accordance with the Declaration of Helsinki. The requirement for written informed consent was waived due to the retrospective design of the study, and study information was disclosed using an opt-out approach.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}